NCYT:LON
Novacyt SA
GBX 39.50
arrow_downward
-0.25%(-0.100) Siku 1
16 Okt, 16:35:25 GMT +1 · GBX
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NCYT...
Fungua
GBX 39.60
Juu
GBX 39.68
Chini
GBX 39.20
Mtaji wa soko
32.41M
Wastani wa kiasi cha mauzo
elfu 102.63
Kiasi cha mauzo ya hisa
elfu 12.22
Juu kwa wiki 52
GBX 86.00
Chini kwa wiki 52
GBX 26.60
Hisa za wawekezaji
37.66M
Idadi ya wafanyakazi
228
Fungua
GBX 39.60
Juu
GBX 39.68
Chini
GBX 39.20
Mtaji wa soko
32.41M
Wastani wa kiasi cha mauzo
elfu 102.63
Kiasi cha mauzo ya hisa
elfu 12.22
Juu kwa wiki 52
GBX 86.00
Chini kwa wiki 52
GBX 26.60
Hisa za wawekezaji
37.66M
Idadi ya wafanyakazi
228
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Binance
·
dakika 15 zilizopita
TradFi News | The S&P 500 Sits Near a Record While Half the Russell 3000 Is Already in a Bear Market
Simply Wall Street
·
dakika 46 zilizopita
Five Year MS Data Might Change The Case For Investing In TG Therapeutics Stock (TGTX)
MarketBeat
·
saa 1 iliyopita
Ideal Power (NASDAQ:IPWR) Stock Breaks Below Two Hundred Day Moving Average - What's Next?
CNN
·
saa 13 zilizopita
Nasdaq sinks more than 2% as investors raise questions about AI debt
Wasifu
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Kuhusu Novacyt SA
Afisa Mkuu Mtendaji (CEO)David Allmond
Wafanyakazi228
Lilianzishwa3 Jul 2006
Makao makuu-
Sekta-
Tovutinovacyt.com